Pneumonia Therapeutics 2018 Global Market Key Players – Pfizer, GlaxoSmithKline, Merck & Co, Allergan – Analysis and Forecast to 2025

About TB Diagnostics 
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio’s analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

Covered in this Report 
The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

Key Geographies 
• Americas 
• APAC 
• EMEA

Key Vendors 
• Abbott 
• Alere 
• Becton, Dickinson 
• F. Hoffmann-La Roche

Other Prominent Vendors 
• Siemens 
• BioMérieux 
• Cepheid 
• Hain Lifescience 
• Hologic 
• Ortho Clinical 
• Epistem UK 
• Eiken Chemical Japan 
• Alere US

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/98746-global-tb-diagnostic-market-2015-2019                              

Market Driver 
• High Prevalence of TB 
• For a full, detailed list, view our report

Market Challenge 
• Insensitivity of Spear Microscopy 
• For a full, detailed list, view our report

Market Trend 
• Intensification of Rapid Tests in Developing Countries 
• For a full, detailed list, view our report

Key Questions Answered in this Report 
• What will the market size be in 2019 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?                                                                                                                                                    

Table Of Contents

1. Executive Summary 
   02. List of Abbreviations 
   03. Scope of the Report 
   03.1 Product Offerings 
   04. Market Research Methodology 
   04.1 Market Research Process 
       04.2 Research Methodology 
   05. Introduction 
   06. Market Landscape 
       06.1 Market Overview 
       06.2 Market Size and Forecast 
       06.3 Five Forces Analysis 
   07. Prevalence and Incidence Rate 
   08. Advances in Technology 
       08.1 Second-generation Nucleic Acid Detection 
       08.2 Next-generation Nucleic Acid Detection 
   09. TB Diagnostics Pipeline 
   10. Market Segmentation by Disease Stage 
       10.1 Global Latent TB Diagnostics Market 
       10.2 Global Active TB Diagnostics Market 
       10.3 Global Drug Susceptibility Tests Market 
   11. Geographical Segmentation 
       11.1 Global TB Diagnostics Market in APAC 
         11.1.1 India 
       11.2 Global TB Diagnostics Market in Americas 
         11.2.1 Brazil 
       11.3 Global TB Diagnostics Market in EMEA 
         11.3.1 South Africa 
   12. Buying Criteria 
   13. Market Growth Drivers 
   14. Drivers and Their Impact 
   15. Market Challenges 
   16. Impact of Drivers and Challenges 
   17. Market Trends 
   18. Trends and Their Impact 
   19. Vendor Landscape 
       19.1 Competitive Scenario 
         19.1.1 Key News 
         19.1.2 Mergers and Acquisitions 
       19.2 Market Share Analysis 2013 
         19.2.1 Abbott Diagnostics 
         19.2.2 Alere 
         19.2.3 BD 
         19.2.4 Roche Diagnostics 
       19.3 Other Prominent Vendors 
   20. Key Vendor Analysis 
       20.1 Abbott Diagnostics 
         20.1.1 Key Facts 
         20.1.2 Business Overview 
         20.1.3 Geographical Presence 
         20.1.4 SWOT Analysis 
       20.2 Alere 
         20.2.1 Key Facts 
         20.2.2 Business Overview 
         20.2.3 Business Segmentation by Revenue 2013 
         20.2.4 Business Segmentation by Revenue 2012 and 2013 
         20.2.5 Geographical Segmentation by Revenue 2013 
         20.2.6 Business Strategy 
         20.2.7 Recent Developments 
         20.2.8 SWOT Analysis 
       20.3 BD 
         20.3.1 Key Facts 
         20.3.2 Business Description 
         20.3.3 Business Segmentation 
         20.3.4 Revenue Segmentation by Business 
         20.3.5 Segmental Revenue Comparison 2013 and 2012 
         20.3.6 Revenue Segmentation by Geography 
         20.3.7 Business Strategy 
         20.3.8 Key Developments 
         20.3.9 SWOT Analysis 
       20.4 Roche Diagnostics 
         20.4.1 Key Facts 
         20.4.2 Business Overview 
         20.4.3 Business Segmentation by Revenue 2014 
         20.4.4 Business Segmentation by Revenue 2013 and 2014 
         20.4.5 Geographical Segmentation by Revenue 2014 
         20.4.6 Business Strategy 
         20.4.7 Recent Developments 
         20.4.8 SWOT Analysis 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/98746-global-tb-diagnostic-market-2015-2019                   

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)